Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)

Condition:   Pulmonary Disease, Chronic Obstructive
Interventions:   Drug: Mepolizumab;   Drug: Placebo
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified April 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days